Regulation - Pricing, Herceptin

Filter

Current filters:

PricingHerceptin

Popular Filters

NICE views breast cancer drugs from GSK and Roche too expensive

14-02-2012

The UK drug watchdog the National Institute for Health and Clinical Excellence (NICE) has published draft…

EuropeGlaxoSmithKlineHerceptinOncologyPharmaceuticalPricingRegulationRocheTyverb

Parexel

Parexel

Back to top